Evidence map›Paper›PMID 36432115›Full record

ArticleMolecules (Basel, Switzerland)2022

Afrah E Mohammed, Sahar S Alghamdi, Nada K Alharbi, Fatma Alshehri, Rasha Saad Suliman, Fahad Al-Dhabaan, Maha Alharbi

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. In silico Prediction ofInternational journal of nanomedicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Afrah E MohammedDepartment of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0003-3294-8560
Sahar S AlghamdiDepartment of Pharmaceutical Sciences, College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia.ORCID 0000-0002-2770-218X
Nada K AlharbiDepartment of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0003-3501-4480
Fatma AlshehriDepartment of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0002-9646-5683
Rasha Saad SulimanDepartment of Pharmacy, Fatima College of Health Sciences, Abu Dhabi 3798, United Arab Emirates.ORCID 0000-0002-6323-0781
Fahad Al-DhabaanDepartment of Biology, College of Science and Humanities, Shaqra University, Ad-Dawadimi 11911, Saudi Arabia.
Maha AlharbiDepartment of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
Princess Nourah bint Abdulrahman University · SAKing Saud bin Abdulaziz University for Health Sciences · SAShaqra University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An in silico approach applying computer-simulated models helps enhance biomedicines by sightseeing the pharmacology of potential therapeutics. Currently, an in silico study combined with in vitro assays investigated the antimicrobial ability of

Indexed as

Metal NanoparticlesPlumbaginaceaeAnti-Bacterial AgentsHumansPlant ExtractsSilverAnti-Bacterial AgentsPlant ExtractsSilverantimicrobialbiomoleculesmolecular dockingpharmacokinetic predictionsilver nanoparticles

Identifiers

PMID36432115
PMCPMC9693928
OpenAlexW4309449693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.